Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to $1.0 billion.

  • Ptc Therapeutics' Short-term Investments rose 10830.77% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 10830.77%. This contributed to the annual value of $360.0 million for FY2024, which is 2732.18% up from last year.
  • As of Q3 2025, Ptc Therapeutics' Short-term Investments stood at $1.0 billion, which was up 10830.77% from $971.8 million recorded in Q2 2025.
  • Ptc Therapeutics' 5-year Short-term Investments high stood at $1.0 billion for Q3 2025, and its period low was $118.8 million during Q1 2023.
  • For the 5-year period, Ptc Therapeutics' Short-term Investments averaged around $463.0 million, with its median value being $438.5 million (2024).
  • Its Short-term Investments has fluctuated over the past 5 years, first crashed by 7757.75% in 2022, then skyrocketed by 27589.26% in 2024.
  • Over the past 5 years, Ptc Therapeutics' Short-term Investments (Quarter) stood at $583.7 million in 2021, then crashed by 77.58% to $130.9 million in 2022, then skyrocketed by 116.04% to $282.7 million in 2023, then increased by 27.32% to $360.0 million in 2024, then surged by 182.01% to $1.0 billion in 2025.
  • Its Short-term Investments stands at $1.0 billion for Q3 2025, versus $971.8 million for Q2 2025 and $546.9 million for Q1 2025.